Opportunistic Infections Citation List:
March 18, 2009 - March 31, 2009
Opportunistic Fungi (Cryptococcus, Aspergillus, Candida, Histoplasma)
1. Synthesis and anti-microbial screening of some Schiff bases of 3-amino-6,8-dibromo-2-phenylquinazolin-4(3H)-ones.
Panneerselvam P, Rather BA, Ravi Sankar Reddy D, Ramesh Kumar N.
Eur J Med Chem. 2009 May;44(5):2328-33. Epub 2008 Apr 29.
PMID: 18603337 [PubMed - in process]
2. Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
Ostrosky-Zeichner L, Paetznick VL, Rodriguez J, Chen E, Sheehan DJ.
Antimicrob Agents Chemother. 2009 Apr;53(4):1639-41. Epub 2009 Jan 12.
PMID: 19139291 [PubMed - in process]
3. Antifungal activity and mode of action of silver nano-particles on Candida albicans.
Kim KJ, Sung WS, Suh BK, Moon SK, Choi JS, Kim JG, Lee DG.
Biometals. 2009 Apr;22(2):235-42. Epub 2008 Sep 4.
PMID: 18769871 [PubMed - in process]
4. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates.
Innocenti A, Hall RA, Schlicker C, Mühlschlegel FA, Supuran CT.
Bioorg Med Chem. 2009 Apr 1;17(7):2654-7. Epub 2009 Mar 5.
PMID: 19297172 [PubMed - in process]
TB (Tuberculosis, Mycobacterium, Avium, Drug Resistant, MAC, MDR)
5. On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture.
Greenstein RJ, Su L, Brown ST.
Int J Infect Dis. 2009 Mar 19. [Epub ahead of print]
PMID: 19303801 [PubMed - as supplied by publisher]
6. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
Upadhayaya RS, Vandavasi JK, Vasireddy NR, Sharma V, Dixit SS, Chattopadhyaya J.
Bioorg Med Chem. 2009 Apr 1;17(7):2830-41. Epub 2009 Feb 21.
PMID: 19285414 [PubMed - in process]
7. Piscidin 4, a novel member of the piscidin family of antimicrobial peptides.
Noga EJ, Silphaduang U, Park NG, Seo JK, Stephenson J, Kozlowicz S.
Comp Biochem Physiol B Biochem Mol Biol. 2009 Apr;152(4):299-305.
PMID: 19266617 [PubMed - in process]
8. Anti-tubercular activity of ruthenium (II) complexes with polypyridines.
Hadda TB, Akkurt M, Baba MF, Daoudi M, Bennani B, Kerbal A, Chohan ZH.
J Enzyme Inhib Med Chem. 2009 Apr;24(2):457-63.
PMID: 18608758 [PubMed - in process]
Citations from the ISI Web of Knowledge Listings for O.I.
9. Rostom S.A.F., et al.
Azole antimicrobial pharmacophore-based tetrazoles: Synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents
BIOORGANIC & MEDICINAL CHEMISTRY 2009 (March) 17: 2410 - 2422